Thursday, April 29, 2021
3–8:30 p.m. EDT
Organizers:
Eugenia Girda, MD, FACOG – Rutgers Cancer Institute of New Jersey
Eric A. Singer, MD, MA, MS, FACS – Rutgers Cancer Institute of New Jersey
Kristen R. Spencer, DO, MPH – Rutgers Cancer Institute of New Jersey
ACI New Brunswick Program
The program has already taken place.
Program Agenda
April 29, 2021, Program
The program is hosted through Zoom Webinar.
|
2:45–3 p.m.
|
Welcome, Introduction, SITC Resources
|
|
Session I: Cancer Immunotherapy
|
|
3–3:30 p.m.
|
Immunotherapy for the Treatment of Head and Neck Cancers
Malini Patel, MD – Rutgers Cancer Institute of New Jersey
|
|
3:30–4 p.m.
|
Immunotherapy for the Treatment of Lung Cancer
Jyoti Malhotra, MD, MPH – Rutgers Cancer Institute of New Jersey
|
|
4–4:30 p.m.
|
Immunotherapy for the Treatment of Hematologic Malignancies
Mansi R. Shah, MD – Rutgers Cancer Institute of New Jersey
|
| 4:30–5 p.m. |
Immunotherapy for the Treatment of Genitourinary Malignancies
Ryan D. Stephenson, DO – Rutgers Cancer Institute of New Jersey
|
| 5–5:15 p.m. |
Break
|
| 5:15–5:45 p.m. |
Immunotherapy for the Treatment of Skin Cancers
Roman Groisberg, MD – Rutgers Cancer Institute of New Jersey
|
| 5:45–6:10 p.m. |
Immunotherapy for the Treatment of Additional Solid Tumors: Gastrointestinal Cancers
Kristen R. Spencer, DO, MPH – Rutgers Cancer Institute of New Jersey
|
| Session II: Immunotherapy Challenges and Beyond |
| 6:10–6:35 p.m. |
Immunotherapy for the Treatment of Additional Solid Tumors: Gynecologic Cancers
Eugenia Girda, MD, FACOG – Rutgers Cancer Institute of New Jersey
|
| 6:35–6:55 p.m. |
Immunotherapy for the Treatment of Additional Solid Tumors: Breast Cancer
Nancy Chan, MD – Rutgers Cancer Institute of New Jersey
|
| 6:55–7:10 p.m. |
Break
|
| 7:10 –7:40 p.m. |
Toxicity Management
Biren Saraiya, MD – Rutgers Cancer Institute of New Jersey
|
| 7:40–8:05 p.m. |
What's Next for Cancer Immunotherapy?
Christian Hinrichs, MD – Rutgers Cancer Institute of New Jersey
|
| 8:05–8:25 p.m. |
COVID-19 in Cancer Immunotherapy
Howard Hochster, MD – Rutgers Cancer Institute of New Jersey
|
8:25–8:30 p.m.
|
Closing Remarks |